Novartis gene therapy approval signals new cancer treatment era – Reuters
Reuters |
Novartis gene therapy approval signals new cancer treatment era
Reuters (Reuters) – Novartis AG on Wednesday won highly anticipated U.S. approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, a $475,000 treatment that marks the start of a potential new treatment paradigm for some cancers. |
